Results 171 to 180 of about 6,247 (199)

Dapagliflozin improves outcomes in HFmrEF and HFpEF

Nature Reviews Cardiology, 2022
openaire   +2 more sources

Dapagliflozin DELIVERs for HFmrEF/HFpEF

Medicom Conference Report ESC 2022, 2022
openaire   +1 more source

Who wants the middle seat?: HFmrEF in a world dominated by HFpEF and HFrEF

Journal of Cardiac Failure, 2023
Peter M, Eckman, Ruben, Crespo
openaire   +2 more sources

Effects of sacubitril/valsartan on clinical symptoms, echocardiographic parameters, and outcomes in HFrEF and HFmrEF patients with coronary heart disease and chronic kidney disease

Current Medical Research and Opinion, 2021
Dongjian Han, Dominick Mkombozi Raphael, Deliang Shen   +2 more
exaly  

Top bar navigation

Frontiers in Cardiovascular Medicine, 2022
JianPing Zeng, Zhican Liu, Haobo Huang
exaly  

Therapie der diastolischen Herzinsuffizienz (HFpEF/HFmrEF): Lichtstreifen am Horizont?

Aktuelle Kardiologie, 2021
Wolfgang von Scheidt
exaly  

Rationale, Design and Baseline Characteristics of the PARAGLIDE-HF Trial: Sacubitril/Valsartan vs Valsartan in HFmrEF and HFpEF With a Worsening Heart Failure Event

Journal of Cardiac Failure, 2023
Jonathan H Ward
exaly  

HFmrEF and HFpEF

JACC: Heart Failure
Virginia Anagnostopoulou, Abhinav Sharma, Pierpaolo Pellicori   +2 more
openaire   +1 more source

HFpEF and HFmrEF: Different Sides of the Same Coin?

2022
openaire   +1 more source

How to Measure DELIVERed Benefits of Dapagliflozin in the Management of HFmrEF/HFpEF?

JACC: Heart Failure, 2023
Atsushi Tanaka, Kosuke Sawami, Koichi Node   +2 more
openaire   +2 more sources